Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 2/20 | 0.78 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.62 |
| ▸ | IGF2R | P11717 | 4/20 | 0.58 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.44 |
| ▸ | UMPS | P11172 | 2/20 | 0.43 |
| ▸ | ATIC | P31939 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4323207 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL15628068 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL977102 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL345396 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL12377166 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL799813 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL48379 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL21926734 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL22107998 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS | |
| SCHEMBL742653 | 1.00 | FBP1 (0.78) | FBP1AMDHD2IGF2RP2RY14UMPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3679065-A1 | SIGNALING AND ANTIGEN-PRESENTING BIFUNCTIONAL RECEPTORS (SABR) | California Institute of Technology (US) | 2020-07-15 | — | — | EP | disclosed |
| WO-2019051001-A1 | SIGNALING AND ANTIGEN-PRESENTING BIFUNCTIONAL RECEPTORS (SABR) | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2019-03-14 | — | — | WO | disclosed |
| WO-1995029255-A1 | LUMINESCENCE-BASED DIAGNOSTICS | MEDILITE DIAGNOSTIKA (US) | 1995-11-02 | — | — | WO | disclosed |
| EP-0660926-A1 | ELECTROPHORETICALLY MEDIATED CHEMICAL ANALYSIS | PURDUE RESEARCH FOUNDATION (US) | 1995-07-05 | — | — | EP | disclosed |
| WO-1994007132-A1 | ELECTROPHORETICALLY MEDIATED CHEMICAL ANALYSIS | PURDUE RESEARCH FOUNDATION (US) | 1994-03-31 | — | — | WO | disclosed |
| US-4663278-A | Agglutination dependent enzyme channeling immunoassay | SYVA COMPANY (US) | 1987-05-05 | — | — | US | disclosed |
| US-4374925-A | PROTEIN BINDING ASSAYS | SYVA COMPANY (US) | 1983-02-22 | — | — | US | disclosed |
| EP-0071087-A1 | Improved determination of creatine phosphokinase in body fluids | SERAGEN DIAGNOSTICS, INC. (US) | 1983-02-09 | — | — | EP | disclosed |
| US-4281061-A | DETECTABLE SIGNAL FROM FLUORESCENT DYE OR LABELED ENZYME | SYVA COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4275149-A | IMMUNOASSAY | SYVA COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| EP-0005867-A1 | An alpha-amylase assay, a reagent composition and a reagent system therefor | COOPERBIOMEDICAL, INC. (US) | 1979-12-12 | — | — | EP | disclosed |